Marburg Virus News and Research

RSS

Marburg virus or simply Marburg is the common name for the the genus of viruses Marburgvirus, which contains one species, ''Lake Victoria marburgvirus''. The virus causes the disease Marburg Hemorrhagic Fever (MHF), also referred to as ''Marburg Virus Disease''.

Scientists unveil new Ebola virus vaccine design

Scientists at Scripps Research have unveiled a new Ebola virus vaccine design, which they say has several advantages over standard vaccine approaches for Ebola and related viruses that continue to threaten global health.

13 May 2021

UTMB researchers receive $11.3 million grant to study immunopathogenesis of Ebola

Researchers at the University of Texas Medical Branch at Galveston have been awarded an $11.3 Million, multi-year grant from the National Institute of Allergy and Infectious Diseases to study immunopathogenesis of Ebola, and in particular to determine why cells infected with Ebola develop "immune system paralysis," which inhibits immune response, leads to hyperinflammation, and allows the deadly infection to spread.

7 May 2021

Researchers report encouraging results from experimental antiviral targeting Marburg virus

The Marburg virus, a relative of the Ebola virus, causes a serious, often-fatal hemorrhagic fever. Transmitted by the African fruit bat and by direct human-to-human contact, Marburg virus disease currently has no approved vaccine or antivirals to prevent or treat it.

7 May 2021

Study shows substantial benefit of combination therapy for advanced Marburg infections

A new study conducted at the Galveston National Laboratory at the The University of Texas Medical Branch at Galveston has shown substantial benefit to combining monoclonal antibodies and the antiviral remdesivir against advanced Marburg virus.

25 Mar 2021

Three commonly used antiviral drugs potentially effective at preventing replication of SARS-CoV-2

An international team of researchers has found that three commonly used antiviral and antimalarial drugs are effective in vitro at preventing replication of SARS-CoV-2, the virus that causes COVID-19.

24 Mar 2021

Georgia State professor receives federal funding to study unique features of Ebola, Marburg viruses

Dr. Christopher Basler, professor and director of the Center for Microbial Pathogenesis in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.94 million federal grant to study unique features of Ebola and Marburg viruses that control how the virus family expresses its genes and escapes immune responses.

15 Jul 2020

Antibodies against prevalent endemic human coronaviruses may provide cross-protection to SARS-CoV-2

Researchers from Qatar have demonstrated that antibody repertoires against endemic human coronaviruses are qualitatively different in children when compared to the general adult population, as well as healthy adult blood bank donors – and they may also provide cross-protection against epidemic/pandemic strains.

23 Jun 2020

Scientists identify new mechanisms that offer protection against Marburg infection

A detailed study of the monoclonal antibodies from a person who survived a Marburg infection led researchers to identify novel mechanisms that contribute protection against the disease, according to the latest findings of a collaborative team led by The University of Texas Medical Branch at Galveston and Vanderbilt University Medical Center.

22 Apr 2020

Remdesivir shows promise in post-infection treatment for COVID-19 disease

The coronavirus disease (COVID-19) has no approved treatment or vaccine as the world grapple with its wrath. The viral infection has so far infected 1.8 million and killed more than 114,000 people. Now, a team of scientists has shown that an experimental antiviral drug, remdesivir, has shown promise in treating patients with severe COVID-19.

13 Apr 2020

Drug for Ebola and MERS effective against COVID-19

A new study published in the Journal of Biological Chemistry has revealed that drug Remdesivir could be useful in treating the deadly COVID-19 or the novel coronavirus that is infecting tens of thousands of people across the world.

1 Mar 2020

Coronavirus vaccine trials commence

The coronavirus disease (COVID-19) outbreak has swept the world, killing 2,770 people and infecting more than 81,000. Amid the health crisis, scientists from across the globe are racing to develop novel therapies and vaccines in the hope of stemming the spread of the deadly virus.

26 Feb 2020

Is COVID-19 the dreaded ‘Disease X' scientists warned us about?

Back in February 2018, the World Health Organization (WHO) talked about a new virus that will emerge and wreak havoc across the globe. Disease X was the term used for this new unknown pathogen that might cause a future epidemic.

23 Feb 2020

Research shows how Ebola virus interacts with human lipids

Robert Stahelin studies some of the world's deadliest viruses. Filoviruses, including Ebola virus and Marburg virus, cause viral hemorrhagic fever with high fatality rates.

16 Feb 2020

Bats' fierce immune response to viruses could drive zoonotic emergence

It's no coincidence that some of the worst viral disease outbreaks in recent years -- SARS, MERS, Ebola, Marburg and likely the newly arrived 2019-nCoV virus -- originated in bats.

10 Feb 2020

Marburg virus detected in fruit bats of Sierra Leone

The Marburg virus is a close relative of the Ebola virus explain researchers. It may also lead to the deadly life threatening hemorrhagic disease in patients as seen with Ebola. Until now there have been no reported cases of Marburg infection in Sierra Leone say health officials. The detection in the bats however could signal the risk the local population might be at or getting infected.

26 Jan 2020

Scientists detect Marburg virus in Sierra Leone fruit bats

Scientists have detected Marburg virus in fruit bats in Sierra Leone, marking the first time the deadly virus has been found in West Africa. Eleven Egyptian rousette fruit bats tested positive for active Marburg virus infection. Research teams caught the bats separately in three health districts.

24 Jan 2020

Marburg Virus News and Research

Further Reading

Scientists unveil new Ebola virus vaccine design

UTMB researchers receive $11.3 million grant to study immunopathogenesis of Ebola

Researchers report encouraging results from experimental antiviral targeting Marburg virus

Study shows substantial benefit of combination therapy for advanced Marburg infections

Three commonly used antiviral drugs potentially effective at preventing replication of SARS-CoV-2

Georgia State professor receives federal funding to study unique features of Ebola, Marburg viruses

Antibodies against prevalent endemic human coronaviruses may provide cross-protection to SARS-CoV-2

Scientists identify new mechanisms that offer protection against Marburg infection

Remdesivir shows promise in post-infection treatment for COVID-19 disease

Drug for Ebola and MERS effective against COVID-19

Coronavirus vaccine trials commence

Is COVID-19 the dreaded ‘Disease X' scientists warned us about?

Research shows how Ebola virus interacts with human lipids

Bats' fierce immune response to viruses could drive zoonotic emergence

Marburg virus detected in fruit bats of Sierra Leone

Scientists detect Marburg virus in Sierra Leone fruit bats

Investigational vaccine protects macaques against four types of hemorrhagic fever viruses

Auburn study explains link between habitat loss and global emergence of infectious diseases

Groundbreaking research could lead to a simple, inexpensive test for Ebola virus

Disease X: an unknown disease that could claim millions of lives

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News